Comparing LSD, psilocybin, and DMT in healthy volunteers
Treatments studied
This study compares how three different psychedelic substances affect your state of mind. The goal is to better understand these altered states, which may help develop future treatments.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must understand German well enough to follow study instructions.
- You should be in good physical and mental health, with no major medical or psychiatric conditions.
- You must not have used hallucinogenic drugs (like LSD or magic mushrooms) more than 20 times or in the last two months.
- You need to avoid drinking too much alcohol (no more than 15 drinks per week) and smoke fewer than 10 cigarettes a day.
- You must be willing to use effective birth control during the study.
- Your body mass index (BMI) should be between 17 and 34.9.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests how psilocybin (the active ingredient in magic mushrooms) affects consciousness by blocking a specific serotonin receptor in the brain. It helps researchers understand why psilocybin causes altered states of mind.
This trial tests how psilocybin, a psychedelic substance, affects your thinking, memory, and brain activity. Researchers want to understand these effects in healthy adults who have used psychedelics before.
This Phase 1/2 study tests psilocybin to see how it affects brain signals and the “content” of thoughts while you are monitored during the study. Because participants must be generally healthy and mentally stable, it may be an option if you meet those safety and medication rules and are comfortable having your brain activity measured.
This study compares a substance called DDH-LSD to LSD to understand how the body processes it. It may help people who are curious about the effects of these substances in a controlled research setting.
This study tests a single dose of a fast-acting psychedelic called 5-MeO-DMT given through a vein. It is only for healthy volunteers who have no medical or mental health conditions and limited previous experience with hallucinogens.
This study looks at how therapists’ personal experience affects their attitude and skills during substance-assisted therapy training. It’s mainly for therapists-in-training, and may help improve how future training and therapy are delivered safely.
Hear when a new Healthy trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.